Epilepsia en personas mayores
Video Experimental Relacionado
Updated: Jul 17, 2026
05:53
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
1University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, UK.
Lancet (London, England)
|May 3, 2000
Resumen
La epilepsia es más común en adultos mayores, a menudo relacionada con otras enfermedades. El tratamiento eficaz con fármacos antiepilépticos puede controlar las convulsiones en el 70% de los pacientes de edad avanzada, mejorando su calidad de vida.
Área de la Ciencia:
- Geriatría La geriatría es la especialidad de la geriatría.
- Neurología Neurología.
- Salud Pública La salud pública.
Sus antecedentes:
- La prevalencia y la incidencia de la epilepsia alcanzan su pico en la edad avanzada, con aproximadamente el 25% de los nuevos casos en personas mayores.
- Muchos adultos mayores con epilepsia tienen también enfermedades neurodegenerativas, cerebrovasculares o neoplásicas.
- La naturaleza impredecible de las convulsiones puede conducir a dificultades en la aceptación del diagnóstico, pérdida de confianza e independencia en los individuos afectados.
Objetivo del estudio:
- Destacar los desafíos y las estrategias óptimas de manejo de la epilepsia en la población anciana.
- Hacer hincapié en el impacto de los trastornos convulsivos de aparición tardía en los sistemas de atención médica y los costos.
- Abogar por programas coordinados de atención médica para mejorar la calidad de vida de los pacientes ancianos con epilepsia.
Principales métodos:
- Revisión de los datos epidemiológicos sobre la epilepsia en adultos mayores.
- Análisis de los resultados del tratamiento con fármacos antiepilépticos.
- Evaluación del impacto de la epilepsia en los recursos de atención médica.
Principales resultados:
- El control completo de las convulsiones es alcanzable en aproximadamente el 70% de los pacientes ancianos con tratamiento con fármacos antiepilépticos.
- Las convulsiones en personas mayores pueden provocar lesiones físicas y disminuir la moral.
- La aparición de la epilepsia en la vejez aumenta la carga sobre las instalaciones de atención médica y los costos asociados.
Conclusiones:
- El manejo óptimo requiere una investigación rápida, un diagnóstico preciso, un tratamiento efectivo y una educación de apoyo al paciente.
- Un enfoque coordinado entre los profesionales de la salud es crucial para mantener la independencia y mejorar la calidad de vida de este grupo vulnerable.
- Abordar la epilepsia de aparición tardía es esencial para gestionar las cargas sanitarias y mejorar los resultados de los pacientes.
Videos de Conceptos Relacionados
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...